Role of blood collagen turnover markers in reverse remodelling following cardiac resynchronisation therapy in advanced heart failure

Elsik, Maros (Primary Chief Investigator (PCI))
Krum, Henry (Chief Investigator (CI))
Schneider, Hans-Gerhard (Chief Investigator (CI))

Epidemiology and Preventive Medicine Alfred Hospital

Project: Research

Status	Finished
Effective start/end date	1/01/07 → 31/12/07

Funding

Pfizer (Australia) (trading as Pfizer Australia Pty Limited): AUD50,000.00